Krumholz Receives the American Heart Association's Clinical Research Prize
Krumholz was recognized “for his work as a founding leader in the field of outcomes research. His work has led to improvements in the quality of care and outcomes for millions of patients nationwide and beyond,” said American Heart Association President Robert A. Harrington, MD, FAHA.
Yale Offers New Medication for Fatal Disease
Yale Medicine physicians were the first in Connecticut to offer a new medication for hereditary transthyretin-mediated amyloidosis (hATTR), a life-threatening genetic mutation that causes transport proteins called transthyretin to cluster together and deposit amyloids in the peripheral nerves, heart, kidney, and gastrointestinal tract.
NIH Grants Fund Image-Guided Therapy After a Heart Attack
A team of researchers from the Yale School of Medicine and the University of Washington will use ultrasound to guide the delivery of theranostic hydrogels into the heart to prevent dilation of the heart post-MI and subsequent heart failure.
New Consensus for Managing Patients Hospitalized with Heart Failure
The American Heart Association estimates that by 2030 more than 8 million Americans will be diagnosed with chronic heart failure (HF). This condition may lead to kidney failure, liver damage, and other complications. The 2019 American College of Cardiology report provides clinical tools to improve the management of HF patients.
Blood Pressure Control Less Likely Among Those Treated in Low-income Areas
People enrolled in a large clinical hypertension management trial were half as likely to control their blood pressure if they received care at clinics and primary care practices in low-income areas, according to new Yale-led research.
Minimizing blood vessel blockage
All cardiac procedures carry a risk of stroke because plaque or calcium buildup can break off in small pieces, ﬂoat up into the brain, and block narrow blood vessels. A highly specialized tool called an embolic protection device is currently used to prevent some of the released debris from reaching the brain.
Gene Plays Role in Early-Onset Heart Disease and Diabetes
When heart disease affects people under age 50, it’s considered “early onset” and experts believe there’s a genetic link. Yale investigators have found that a particular gene is common to families with multiple members who either have early-onset heart disease or are at risk for it.